Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development

Acta Pharmacologica Sinica

Volumn 29, Issue 2, 2008, Pages 231-238

  Wang, Hui ^a   Ping, Jie ^a   Peng, Ren Xiu ^a   Yue, Jiang ^a   Xia, Xue Yan ^a   Li, Qi Xiong ^a   Kong, Rui ^a   Hong, Jun Yan ^a,b  

^a WUHAN UNIVERSITY   (China)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Adrenal; Cytochrome P450; Glutathione S transferase; Human fetus; Uridine diphosphoglucuronyl transferase

Indexed keywords

CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A7; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HYMECROMONE; ISOENZYME; MESSENGER RNA; XENOBIOTIC AGENT;

ADRENAL GLAND; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBSTRATE; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS LIVER; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENAL GLANDS; ADULT; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; GLUTATHIONE TRANSFERASE; HUMANS; LIVER; MALE; PREGNANCY; SUBCELLULAR FRACTIONS; XENOBIOTICS;

EID: 38749107233     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00738.x     Document Type: Article

References (36)

1. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004 43 : 487 514.
2. Blake MJ, Castro L, Leeder JS, Kearns GL. Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 2005 10 : 123 38.
3. Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome CYP-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005 227 : 115 24.
4. Choudhary D, Jansson I, Sarfarazi M, Schenkman JB. Xenobiotic- metabolizing cytochromes CYP in ontogeny: evolving perspective. Drug Metab Rev 2004 36 : 549 68.
5. Philpot RM. Characterization of cytochrome CYP in extrahepatic tissues. Methods Enzymol 1991 206 : 623 31.
6. Coon MJ. Cytochrome CYP: nature's most versatile biological catalyst. Annu Rev Pharmacol Toxicol 2005 45 : 1 25.
7. Briggs GG. Drug effects on the fetus and breast-fed infant. Clin Obstet Gynecol 2002 45 : 6 21.
8. Rainey WE, Rehman KS, Carr BR. The human fetal adrenal: making adrenal androgens for placental estrogens. Semin Reprod Med 2004 22 : 327 36.
9. Langlois D, Li JY, Saez JM. Development and function of the human fetal adrenal cortex. J Pediatr Endocrinol Metab 2002 5 : 1311 22.
10. Albrecht ED, Henson MC, Walker ML, Pepe GJ. Modulation of adrenocorticotropin-treated baboon fetal adrenal dehydroe-piandrosterone formation in vitro by estrogen at mid- and late gestation. Endocrinology 1990 126 : 3083 8.
11. Sarasin A, Schlumpf M, Muller M. Adrenal-mediated rather than direct effects of nicotine as a basis of altered sex steroid synthesis in fetal and neonatal rat. Reprod Toxicol 2003 17 : 153 62.
12. Wang H, Huang M, Peng RX, Je J. Influences of 3-methylcholanthrene, phenobarbital and dexamethasone on xenobiotic metabolizing-related cytochrome P450 enzymes and steroidogenesis in human fetal adrenal cortical cells. Acta Pharmacol Sin 2006 27 : 1093 6.
13. Chen M, Wang T, Liao ZX, Pan XL, Feng YH, Wang H. Nicotine-induced prenatal overexposure to maternal glucocorticoid and intrauterine growth retardation in rat. Exp Toxicol Pathol. 2007 Sep 17; [Epub ahead of print].
14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 : 265 75.
15. Burke MD, Prough RA, Mayer RT. Characteristics of a microso-mal cytochrome P-448-mediated reaction. Ethoxyresorufin O-deethylation. Drug Metab Dispos 1977 5 : 1 8.
16. Denton TT, Zhang X, Cashman JR. Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochem Pharmacol 2004 67 : 751 6.
17. Peng RX, Lei SB, Gao P. The capacity of drug metabolism in Chinese fetal livers: metabolism of ethylomorphine, aminopyrine and aniline. Asian Pac J Pharmarcol 1990 5 : 13 8.
18. Sanwald P, Blankson EA, Dulery BD, Schoun J, Huebert ND, Dow J. Isocratic high-performance liquid chromatographic method for the separation of testosterone metabolites. J Chromatogr B 1995 672 : 207 15.
19. Li Y. Study on phase II enzymes of drug metabolism. In : Zhang JT, editor Modern methods of pharmacological experiment. Peking : The Union Press of Peking Medical University and Chinese Academy of Medical Sciences 1997. p 1656 7 (in Chinese).
20. Ouwerkerk-Mahadevan S, Mulder GJ. Inhibition of glutathione conjugation in the rat in vivo by analogues of glutathione conjugates. Chem Biol Interact 1998 111-112 : 163 76.
21. Van Iersel ML, van Lipzig MM, Rietjens IM, Vervoort J, van Bladeren PJ. GSTP1-1 stereospecifically catalyzes glutathione conjugation of ethacrynic acid. FEBS Lett 1998 441 : 153 7.
22. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Maenpaa J, et al. Expression of xenobiotic-metabolizing cyto-chrome CYP forms in human adult and fetal liver. Biochem Pharmacol 1994 48 : 59 64.
23. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. Expression of CYP3A in the human liver - evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997 247 : 625 34.
24. Young AM, Allen CE, Audus KL. Efflux transporters of the human placenta. Adv Drug Deliv Rev. 2003 55 : 125 32.
25. Yan YE, Wang H, Feng YH. Alterations of placental cytochrome P450 1A1 and P-glycoprotein in tobacco-induced intrauterine growth retardation in rats. Acta Pharmacol Sin 2005 26 : 1387 94.
26. Yan GL. Fetal endocrinology. Peking : People's Medical Publishing House 1983. p 24 (in Chinese).
27. Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes CYP 1A1 and 1B1. Cancer Sci 2004 95 : 1 6.
28. Omiecinski CJ, Redlich CA, Costa P. Induction and developmental expression of cytochrome CYP1A1 messager RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res 1990 50 : 4315 21.
29. Gu J, Su T, Chen Y, Zhang QY, Ding X. Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity. Toxicol Appl Pharmacol 2000 165 : 158 61.
30. Roberts BJ, Shoaf SE, Jeong KS, Song BJ. Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem Biophys Res Commun 1994 205 : 1064 71.
31. Wilkening S, Bader A. Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. Basic Clin Pharmacol Toxicol 2004 95 : 92 3.
32. Ring JA, Ghabrial H, Ching MS, Smallwood RA, Morgan DJ. Fetal hepatic drug elimination. Pharmacol Ther 1999 84 : 429 45.
33. Hume R, Coughtrie MW, Burchell B. Differential localisation of UDP-glucuronosyltransferase in kidney during human embryonic and fetal development. Arch Toxicol 1995 69 : 242 7.
34. Chauhan D P, Miller MS, Owens IS, Anderson LM. Gene expression, ontogeny and transplacental induction of hepatic UDP-glucuronosyl transferase activity in mice. Dev Pharmacol Ther 1991 16 : 139 49.
35. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 2004 6 : 289 300.
36. Mera N, Ohmori S, Itahashi K, Kiuchi M, Igarashi T, Rikihisa T, et al. Immunochemical evidence for the occurrence of Mu class glutathione S-transferase in human fetal livers. J Biochem 1994 116 : 315 20.